| Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications E Tasciotti, X Liu, R Bhavane, K Plant, AD Leonard, BK Price, ... Nature nanotechnology 3 (3), 151-157, 2008 | 817 | 2008 |
| Sustained small interfering RNA delivery by mesoporous silicon particles T Tanaka, LS Mangala, PE Vivas-Mejia, R Nieves-Alicea, AP Mann, ... Cancer research 70 (9), 3687-3696, 2010 | 372 | 2010 |
| Indocyanine green fluorescence in second near-infrared (NIR-II) window Z Starosolski, R Bhavane, KB Ghaghada, SA Vasudevan, A Kaay, ... PloS one 12 (11), e0187563, 2017 | 208 | 2017 |
| The association of silicon microparticles with endothelial cells in drug delivery to the vasculature RE Serda, J Gu, RC Bhavane, XW Liu, C Chiappini, P Decuzzi, M Ferrari Biomaterials 30 (13), 2440-2448, 2009 | 205 | 2009 |
| Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation B Godin, J Gu, RE Serda, R Bhavane, E Tasciotti, C Chiappini, X Liu, ... Journal of biomedical materials research Part A 94 (4), 1236-1243, 2010 | 171 | 2010 |
| NIR-II fluorescence imaging using indocyanine green nanoparticles R Bhavane, Z Starosolski, I Stupin, KB Ghaghada, A Annapragada Scientific reports 8 (1), 14455, 2018 | 106 | 2018 |
| Thioaptamer conjugated liposomes for tumor vasculature targeting AP Mann, RC Bhavane, A Somasunderam, BL Montalvo-Ortiz, ... Oncotarget 2 (4), 298, 2011 | 104 | 2011 |
| Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent R Bhavane, C Badea, KB Ghaghada, D Clark, D Vela, A Moturu, ... Circulation: Cardiovascular Imaging 6 (2), 285-294, 2013 | 81 | 2013 |
| Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery R Bhavane, E Karathanasis, AV Annapragada Journal of Controlled Release 93 (1), 15-28, 2003 | 79 | 2003 |
| Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice EA Tanifum, I Dasgupta, M Srivastava, RC Bhavane, L Sun, J Berridge, ... PloS one 7 (10), e48515, 2012 | 75 | 2012 |
| Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles E Tasciotti, B Godin, JO Martinez, C Chiappini, R Bhavane, X Liu, ... Molecular imaging 10 (1), 7290.2011. 00011, 2011 | 74 | 2011 |
| Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery E Karathanasis, AL Ayyagari, R Bhavane, RV Bellamkonda, ... Journal of Controlled Release 103 (1), 159-175, 2005 | 74 | 2005 |
| Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta KB Ghaghada, ZA Starosolski, S Bhayana, I Stupin, CV Patel, ... Placenta 57, 60-70, 2017 | 45 | 2017 |
| Multistage nanovectors enhance the delivery of free and encapsulated drugs J O Martinez, M Evangelopoulos, R Bhavane, S Acciardo, F Salvatore, ... Current drug targets 16 (14), 1582-1590, 2015 | 40 | 2015 |
| Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats E Karathanasis, R Bhavane, AV Annapragada International Journal of Nanomedicine 2 (3), 501-513, 2007 | 35 | 2007 |
| A liposomal Gd contrast agent does not cross the mouse placental barrier AN Shetty, R Pautler, K Ghaghada, D Rendon, H Gao, Z Starosolski, ... Scientific Reports 6 (1), 27863, 2016 | 34 | 2016 |
| Triggered release of ciprofloxacin from nanostructured agglomerated vesicles R Bhavane, E Karathanasis, AV Annapragada International Journal of Nanomedicine 2 (3), 407-418, 2007 | 23 | 2007 |
| Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats E Karathanasis, R Bhavane, AV Annapragada Journal of controlled release 113 (2), 117-127, 2006 | 22 | 2006 |
| Rational Design of a Self‐Assembling High Performance Organic Nanofluorophore for Intraoperative NIR‐II Image‐Guided Tumor Resection of Oral Cancer X Sun, PK Chintakunta, AA Badachhape, R Bhavane, HJ Lee, DS Yang, ... Advanced Science 10 (10), 2206435, 2023 | 13 | 2023 |
| A novel MRI contrast agent for identifying hyperphosphorylative neurons as a marker of future tau pathology: Neuroimaging: Novel imaging methods A Badachhape, PA Parekh, Q Mu, R Bhavane, M Srivastava, I Stupin, ... Alzheimer's & Dementia 16, e041080, 2020 | 5 | 2020 |
